Sotrovimab Biosimilar – Research Grade
ichorbio’s sotrovimab biosimilar for Research Use Only (RUO) and not for therapeutic use.
SARS-CoV-2 Spike Protein
ichorbio’s sotrovimab biosimilar is available in the following sizes:
1mg, 5mg, 10mg, 20mg, 50mg, 100mg
Uses the same sequence as the therapeutic antibody sotrovimab
Detects SARS-CoV-2 Spike Protein.
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Sterile, preservative-free, solution in PBS. BSA and Azide free.
>95% by SDS-PAGE
≤ 1.0 EU/mg as determined by the LAL method
This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
This biosimilar is strictly for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
There are no reviews yet.